Recent Finacing
Recent Raise
4D Molecular Therapeutics engineers AAV vectors using Therapeutic Vector Evolution to target tissues and delivery routes, enhance transduction and antibody evasion for ophthalmology, pulmonary, neuromuscular and lysosomal gene therapies.
